Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-12

AUTHORS

Virginia Albiñana, Rosa María Jiménez Escribano, Isabel Soler, Luis Rodríguez Padial, Lucia Recio-Poveda, Karina Villar Gómez de las Heras, Luisa María Botella

ABSTRACT

BACKGROUND: Von Hippel-Lindau (VHL) disease is a rare oncological disease with an incidence of 1:36,000, and is characterized by the growth of different types of tumours. Haemangioblastomas in the central nervous system (CNS) and retina, renal carcinoma and pheochromocytomas are the most common tumours. The absence of treatment for VHL leads to the need of repeated surgeries as the only option for these patients. Targeting VHL-derived tumours with drugs with reduced side effects is urgent to avoid repeated CNS surgeries. Recent reports have demonstrated that propranolol, a β-blocker used for the treatment of hypertension and other cardiac and neurological diseases, is the best option for infantile hemangioma (IH). Propranolol could be an efficient treatment to control haemangioblastoma growth in VHL disease given its antiangiogenic effects that were recently demonstrated by us. The main objective of the present study was the assessment of the efficacy and safety of propranolol on retinal haemangioblastoma in von Hippel-Lindau disease (VHL). METHODS: 7 VHL patients, from different regions of Spain, affected from juxtapapillary or peripheral haemangioblastomas were administered 120 mg propranolol daily. Patients were evaluated every 3 months for 12 months, at Virgen de la Salud Hospital (Toledo). The patients had juxtapapillary or peripheral haemangioblastomas but had refused standard treatments. RESULTS: Propranolol was initiated with a progressive increase up to a final dose of 120 mg daily. All tumours remained stable, and no new tumours appeared. The reabsorption of retinal exudation was noted in the two patients having exudates. No adverse effects were recorded. VEGF and miRNA 210 levels were monitored in the plasma of patients as possible biomarkers of VHL. These levels decreased in all cases from the first month of treatment. CONCLUSIONS: Although more studies are necessary, the results of this work suggest that propranolol is a drug to be considered in the treatment of VHL patients with retinal haemangioblastomas. VEGF and miRNA 210 could be used as biomarkers of the VHL disease activity. TRIAL REGISTRATION: The study has a clinical trial design and was registered at EU Clinical Trials Register and Spanish Clinical Studies Registry, EudraCT Number: 2014-003671-30 . Registered 2 September 2014. More... »

PAGES

122

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13023-017-0664-7

DOI

http://dx.doi.org/10.1186/s13023-017-0664-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1090300842

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28662711


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemangioblastoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "MicroRNAs", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Propranolol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Real-Time Polymerase Chain Reaction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retinal Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vascular Endothelial Growth Factor A", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "von Hippel-Lindau Disease", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Centre for Biomedical Network Research on Rare Diseases", 
          "id": "https://www.grid.ac/institutes/grid.452372.5", 
          "name": [
            "Centro de Investigaciones Biol\u00f3gicas, CSIC, Madrid, Spain", 
            "Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Albi\u00f1ana", 
        "givenName": "Virginia", 
        "id": "sg:person.01020207777.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01020207777.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Virgen de la Salud", 
          "id": "https://www.grid.ac/institutes/grid.413514.6", 
          "name": [
            "Hospital Virgen de la Salud (SESCAM), Toledo, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Escribano", 
        "givenName": "Rosa Mar\u00eda Jim\u00e9nez", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Virgen de la Salud", 
          "id": "https://www.grid.ac/institutes/grid.413514.6", 
          "name": [
            "Hospital Virgen de la Salud (SESCAM), Toledo, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Soler", 
        "givenName": "Isabel", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Virgen de la Salud", 
          "id": "https://www.grid.ac/institutes/grid.413514.6", 
          "name": [
            "Hospital Virgen de la Salud (SESCAM), Toledo, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Padial", 
        "givenName": "Luis Rodr\u00edguez", 
        "id": "sg:person.01322311471.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322311471.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro de Investigaciones Biol\u00f3gicas", 
          "id": "https://www.grid.ac/institutes/grid.418281.6", 
          "name": [
            "Centro de Investigaciones Biol\u00f3gicas, CSIC, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Recio-Poveda", 
        "givenName": "Lucia", 
        "id": "sg:person.01047674527.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047674527.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Servicio de Salud de Castilla La Mancha", 
          "id": "https://www.grid.ac/institutes/grid.426047.3", 
          "name": [
            "SSCC - Servicio de Salud de Castilla-La Mancha (SESCAM), Toledo, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Villar G\u00f3mez de las Heras", 
        "givenName": "Karina", 
        "id": "sg:person.07742071351.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07742071351.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre for Biomedical Network Research on Rare Diseases", 
          "id": "https://www.grid.ac/institutes/grid.452372.5", 
          "name": [
            "Centro de Investigaciones Biol\u00f3gicas, CSIC, Madrid, Spain", 
            "Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Botella", 
        "givenName": "Luisa Mar\u00eda", 
        "id": "sg:person.01057140447.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01057140447.98"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.ijporl.2011.01.028", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001699378"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ophtha.2008.04.033", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003738503"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jcjo.2014.07.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009229111"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.oftal.2011.10.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009711802"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.33.5422", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009936880"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.pdpdt.2015.10.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012392419"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18632/oncotarget.197", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014843950"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.semcancer.2012.05.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018462490"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmc0708819", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019302191"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/eye.2012.259", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019328739", 
          "https://doi.org/10.1038/eye.2012.259"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00417-014-2660-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021055943", 
          "https://doi.org/10.1007/s00417-014-2660-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13023-015-0343-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021469829", 
          "https://doi.org/10.1186/s13023-015-0343-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4103/0378-6323.51238", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022652823"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.pdpdt.2014.02.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023357042"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ajo.2006.02.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024129914"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18632/oncotarget.343", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024984930"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5966/sctm.2015-0076", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026196688"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(03)13643-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026836976"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(03)13643-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026836976"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0420.2006.00825.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028490917"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jcma.2013.09.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030334455"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jcma.2013.09.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030334455"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.vph.2010.08.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032262192"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.iae.0000244659.62202.ee", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033390356"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.iae.0000244659.62202.ee", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033390356"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ejhg.2010.175", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034174369", 
          "https://doi.org/10.1038/ejhg.2010.175"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0009922813492885", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034690595"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0009922813492885", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034690595"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.wneu.2015.11.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038518597"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1101/cshperspect.a006460", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039269309"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0929-693x(12)71167-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043411777"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10517-006-0249-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046930187", 
          "https://doi.org/10.1007/s10517-006-0249-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10517-006-0249-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046930187", 
          "https://doi.org/10.1007/s10517-006-0249-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2133.2010.09848.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050039524"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2133.2010.09848.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050039524"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-011-1505-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051311429", 
          "https://doi.org/10.1007/s10549-011-1505-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1755-3768.2009.01611.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052912596"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1755-3768.2009.01611.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052912596"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0031-1291300", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057249368"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/qjmed/77.2.1151", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059986214"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1160/th11-11-0809", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063292920"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1542/peds.2008-3458", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1067827626"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/2011.12.peds11503", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071076434"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/2011.12.peds11503", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071076434"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/2011.12.peds11503", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071076434"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/2011.12.peds11503", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071076434"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3892/mmr.2015.4170", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071523119"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3892/mmr.2015.4170", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071523119"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5301/ejo.5000322", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072751105"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5301/ejo.5000322", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072751105"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077312261", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078585829", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083003894", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-12", 
    "datePublishedReg": "2017-12-01", 
    "description": "BACKGROUND: Von Hippel-Lindau (VHL) disease is a rare oncological disease with an incidence of 1:36,000, and is characterized by the growth of different types of tumours. Haemangioblastomas in the central nervous system (CNS) and retina, renal carcinoma and pheochromocytomas are the most common tumours. The absence of treatment for VHL leads to the need of repeated surgeries as the only option for these patients. Targeting VHL-derived tumours with drugs with reduced side effects is urgent to avoid repeated CNS surgeries. Recent reports have demonstrated that propranolol, a \u03b2-blocker used for the treatment of hypertension and other cardiac and neurological diseases, is the best option for infantile hemangioma (IH). Propranolol could be an efficient treatment to control haemangioblastoma growth in VHL disease given its antiangiogenic effects that were recently demonstrated by us. The main objective of the present study was the assessment of the efficacy and safety of propranolol on retinal haemangioblastoma in von Hippel-Lindau disease (VHL).\nMETHODS: 7 VHL patients, from different regions of Spain, affected from juxtapapillary or peripheral haemangioblastomas were administered 120\u00a0mg propranolol daily. Patients were evaluated every 3\u00a0months for 12\u00a0months, at Virgen de la Salud Hospital (Toledo). The patients had juxtapapillary or peripheral haemangioblastomas but had refused standard treatments.\nRESULTS: Propranolol was initiated with a progressive increase up to a final dose of 120\u00a0mg daily. All tumours remained stable, and no new tumours appeared. The reabsorption of retinal exudation was noted in the two patients having exudates. No adverse effects were recorded. VEGF and miRNA 210 levels were monitored in the plasma of patients as possible biomarkers of VHL. These levels decreased in all cases from the first month of treatment.\nCONCLUSIONS: Although more studies are necessary, the results of this work suggest that propranolol is a drug to be considered in the treatment of VHL patients with retinal haemangioblastomas. VEGF and miRNA 210 could be used as biomarkers of the VHL disease activity.\nTRIAL REGISTRATION: The study has a clinical trial design and was registered at EU Clinical Trials Register and Spanish Clinical Studies Registry, EudraCT Number: 2014-003671-30 . Registered 2 September 2014.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s13023-017-0664-7", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1036535", 
        "issn": [
          "1750-1172"
        ], 
        "name": "Orphanet Journal of Rare Diseases", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "name": "Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease", 
    "pagination": "122", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "9ac68f06dda968fd727de3c10d6f496df9aedf4c086e72857ede3c9849efd8de"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28662711"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101266602"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13023-017-0664-7"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1090300842"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13023-017-0664-7", 
      "https://app.dimensions.ai/details/publication/pub.1090300842"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T10:29", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000349_0000000349/records_113641_00000004.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs13023-017-0664-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13023-017-0664-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13023-017-0664-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13023-017-0664-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13023-017-0664-7'


 

This table displays all metadata directly associated to this object as RDF triples.

304 TRIPLES      21 PREDICATES      85 URIs      36 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13023-017-0664-7 schema:about N073e299967c2441596e811be74c6dcb3
2 N0912f6f0ea25458bb057dfc5132a8612
3 N140795b3f3624583a04ca9b664467386
4 N3efd6f14125646b19fb0028e59a52dd4
5 N4798205359ee4c73be05172157279ea8
6 N5ec380f6a5ed4766967e0d483b469e93
7 N659e1c27fa4640fea522e1626d069307
8 N82d958acd4114bc098c581c0cf312727
9 N8a98b9662a524ef6a3064dc2d40be3db
10 Na5509a3c61014dbe8464489778d3c6b2
11 Naa57bc869db848b2b02046d63c4f984a
12 Nb44c0455a03c4b6fa3d3593325290713
13 Nb6f849e0131f47e4a939af973b6934f2
14 Nbc8d3e6fd31246598c6d6b63492382a0
15 Nce3b6f0186a54b1392102c576070ed9a
16 anzsrc-for:11
17 anzsrc-for:1103
18 schema:author N0210c1fdab46411dabde6e1c82739f97
19 schema:citation sg:pub.10.1007/s00417-014-2660-0
20 sg:pub.10.1007/s10517-006-0249-2
21 sg:pub.10.1007/s10549-011-1505-3
22 sg:pub.10.1038/ejhg.2010.175
23 sg:pub.10.1038/eye.2012.259
24 sg:pub.10.1186/s13023-015-0343-5
25 https://app.dimensions.ai/details/publication/pub.1077312261
26 https://app.dimensions.ai/details/publication/pub.1078585829
27 https://app.dimensions.ai/details/publication/pub.1083003894
28 https://doi.org/10.1016/j.ajo.2006.02.011
29 https://doi.org/10.1016/j.ijporl.2011.01.028
30 https://doi.org/10.1016/j.jcjo.2014.07.007
31 https://doi.org/10.1016/j.jcma.2013.09.001
32 https://doi.org/10.1016/j.oftal.2011.10.005
33 https://doi.org/10.1016/j.ophtha.2008.04.033
34 https://doi.org/10.1016/j.pdpdt.2014.02.013
35 https://doi.org/10.1016/j.pdpdt.2015.10.008
36 https://doi.org/10.1016/j.semcancer.2012.05.005
37 https://doi.org/10.1016/j.vph.2010.08.002
38 https://doi.org/10.1016/j.wneu.2015.11.003
39 https://doi.org/10.1016/s0140-6736(03)13643-4
40 https://doi.org/10.1016/s0929-693x(12)71167-3
41 https://doi.org/10.1055/s-0031-1291300
42 https://doi.org/10.1056/nejmc0708819
43 https://doi.org/10.1093/qjmed/77.2.1151
44 https://doi.org/10.1097/01.iae.0000244659.62202.ee
45 https://doi.org/10.1101/cshperspect.a006460
46 https://doi.org/10.1111/j.1365-2133.2010.09848.x
47 https://doi.org/10.1111/j.1600-0420.2006.00825.x
48 https://doi.org/10.1111/j.1755-3768.2009.01611.x
49 https://doi.org/10.1160/th11-11-0809
50 https://doi.org/10.1177/0009922813492885
51 https://doi.org/10.1200/jco.2010.33.5422
52 https://doi.org/10.1542/peds.2008-3458
53 https://doi.org/10.18632/oncotarget.197
54 https://doi.org/10.18632/oncotarget.343
55 https://doi.org/10.3171/2011.12.peds11503
56 https://doi.org/10.3892/mmr.2015.4170
57 https://doi.org/10.4103/0378-6323.51238
58 https://doi.org/10.5301/ejo.5000322
59 https://doi.org/10.5966/sctm.2015-0076
60 schema:datePublished 2017-12
61 schema:datePublishedReg 2017-12-01
62 schema:description BACKGROUND: Von Hippel-Lindau (VHL) disease is a rare oncological disease with an incidence of 1:36,000, and is characterized by the growth of different types of tumours. Haemangioblastomas in the central nervous system (CNS) and retina, renal carcinoma and pheochromocytomas are the most common tumours. The absence of treatment for VHL leads to the need of repeated surgeries as the only option for these patients. Targeting VHL-derived tumours with drugs with reduced side effects is urgent to avoid repeated CNS surgeries. Recent reports have demonstrated that propranolol, a β-blocker used for the treatment of hypertension and other cardiac and neurological diseases, is the best option for infantile hemangioma (IH). Propranolol could be an efficient treatment to control haemangioblastoma growth in VHL disease given its antiangiogenic effects that were recently demonstrated by us. The main objective of the present study was the assessment of the efficacy and safety of propranolol on retinal haemangioblastoma in von Hippel-Lindau disease (VHL). METHODS: 7 VHL patients, from different regions of Spain, affected from juxtapapillary or peripheral haemangioblastomas were administered 120 mg propranolol daily. Patients were evaluated every 3 months for 12 months, at Virgen de la Salud Hospital (Toledo). The patients had juxtapapillary or peripheral haemangioblastomas but had refused standard treatments. RESULTS: Propranolol was initiated with a progressive increase up to a final dose of 120 mg daily. All tumours remained stable, and no new tumours appeared. The reabsorption of retinal exudation was noted in the two patients having exudates. No adverse effects were recorded. VEGF and miRNA 210 levels were monitored in the plasma of patients as possible biomarkers of VHL. These levels decreased in all cases from the first month of treatment. CONCLUSIONS: Although more studies are necessary, the results of this work suggest that propranolol is a drug to be considered in the treatment of VHL patients with retinal haemangioblastomas. VEGF and miRNA 210 could be used as biomarkers of the VHL disease activity. TRIAL REGISTRATION: The study has a clinical trial design and was registered at EU Clinical Trials Register and Spanish Clinical Studies Registry, EudraCT Number: 2014-003671-30 . Registered 2 September 2014.
63 schema:genre research_article
64 schema:inLanguage en
65 schema:isAccessibleForFree true
66 schema:isPartOf Na0c518d68b3548f3ac4736b6e7562df8
67 Nd47c5204c0b446df92840c368845f45d
68 sg:journal.1036535
69 schema:name Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease
70 schema:pagination 122
71 schema:productId N619466ddff944d93938956bec17dcde6
72 Na6913909f17f4dc88f89e341b57c1ce1
73 Nb45fb5566887459eba8814f80f2ae540
74 Nd3e42bbb15fb4d7a9a4c4da9282b94e5
75 Ne3c765a2e25a44a297eb3c0ba8992acf
76 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090300842
77 https://doi.org/10.1186/s13023-017-0664-7
78 schema:sdDatePublished 2019-04-11T10:29
79 schema:sdLicense https://scigraph.springernature.com/explorer/license/
80 schema:sdPublisher N07955411337643aa8ed0f3f1997ed6ee
81 schema:url https://link.springer.com/10.1186%2Fs13023-017-0664-7
82 sgo:license sg:explorer/license/
83 sgo:sdDataset articles
84 rdf:type schema:ScholarlyArticle
85 N0210c1fdab46411dabde6e1c82739f97 rdf:first sg:person.01020207777.87
86 rdf:rest Ne5ad4b25372f4bcb896f36474f7c74e2
87 N073e299967c2441596e811be74c6dcb3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Propranolol
89 rdf:type schema:DefinedTerm
90 N07955411337643aa8ed0f3f1997ed6ee schema:name Springer Nature - SN SciGraph project
91 rdf:type schema:Organization
92 N0912f6f0ea25458bb057dfc5132a8612 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Female
94 rdf:type schema:DefinedTerm
95 N140795b3f3624583a04ca9b664467386 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name von Hippel-Lindau Disease
97 rdf:type schema:DefinedTerm
98 N27dc8c0323914ecea8d4b7cd247338e8 schema:affiliation https://www.grid.ac/institutes/grid.413514.6
99 schema:familyName Escribano
100 schema:givenName Rosa María Jiménez
101 rdf:type schema:Person
102 N3efd6f14125646b19fb0028e59a52dd4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Young Adult
104 rdf:type schema:DefinedTerm
105 N4798205359ee4c73be05172157279ea8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Adult
107 rdf:type schema:DefinedTerm
108 N5865df9af61741c8bf22a6733ea20aa7 rdf:first N9513452f15bd42d8a6e9f0dc549dc2aa
109 rdf:rest Nb091424a12f042dca6f59dbce770a166
110 N5ec380f6a5ed4766967e0d483b469e93 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Adolescent
112 rdf:type schema:DefinedTerm
113 N619466ddff944d93938956bec17dcde6 schema:name pubmed_id
114 schema:value 28662711
115 rdf:type schema:PropertyValue
116 N659e1c27fa4640fea522e1626d069307 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name MicroRNAs
118 rdf:type schema:DefinedTerm
119 N82d958acd4114bc098c581c0cf312727 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Retinal Diseases
121 rdf:type schema:DefinedTerm
122 N8a98b9662a524ef6a3064dc2d40be3db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Hemangioblastoma
124 rdf:type schema:DefinedTerm
125 N9513452f15bd42d8a6e9f0dc549dc2aa schema:affiliation https://www.grid.ac/institutes/grid.413514.6
126 schema:familyName Soler
127 schema:givenName Isabel
128 rdf:type schema:Person
129 Na0c518d68b3548f3ac4736b6e7562df8 schema:issueNumber 1
130 rdf:type schema:PublicationIssue
131 Na5509a3c61014dbe8464489778d3c6b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Middle Aged
133 rdf:type schema:DefinedTerm
134 Na6913909f17f4dc88f89e341b57c1ce1 schema:name readcube_id
135 schema:value 9ac68f06dda968fd727de3c10d6f496df9aedf4c086e72857ede3c9849efd8de
136 rdf:type schema:PropertyValue
137 Naa57bc869db848b2b02046d63c4f984a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Biomarkers
139 rdf:type schema:DefinedTerm
140 Nb091424a12f042dca6f59dbce770a166 rdf:first sg:person.01322311471.10
141 rdf:rest Ncf06eee82e874005bfd3a253ed384f5e
142 Nb44c0455a03c4b6fa3d3593325290713 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Humans
144 rdf:type schema:DefinedTerm
145 Nb45fb5566887459eba8814f80f2ae540 schema:name dimensions_id
146 schema:value pub.1090300842
147 rdf:type schema:PropertyValue
148 Nb6f849e0131f47e4a939af973b6934f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Real-Time Polymerase Chain Reaction
150 rdf:type schema:DefinedTerm
151 Nbc8d3e6fd31246598c6d6b63492382a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Vascular Endothelial Growth Factor A
153 rdf:type schema:DefinedTerm
154 Nbec00f8ada0146eb85b037c96f65f12f rdf:first sg:person.07742071351.62
155 rdf:rest Nded9a64823364e819e2b887d12382307
156 Nce3b6f0186a54b1392102c576070ed9a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Male
158 rdf:type schema:DefinedTerm
159 Ncf06eee82e874005bfd3a253ed384f5e rdf:first sg:person.01047674527.54
160 rdf:rest Nbec00f8ada0146eb85b037c96f65f12f
161 Nd3e42bbb15fb4d7a9a4c4da9282b94e5 schema:name doi
162 schema:value 10.1186/s13023-017-0664-7
163 rdf:type schema:PropertyValue
164 Nd47c5204c0b446df92840c368845f45d schema:volumeNumber 12
165 rdf:type schema:PublicationVolume
166 Nded9a64823364e819e2b887d12382307 rdf:first sg:person.01057140447.98
167 rdf:rest rdf:nil
168 Ne3c765a2e25a44a297eb3c0ba8992acf schema:name nlm_unique_id
169 schema:value 101266602
170 rdf:type schema:PropertyValue
171 Ne5ad4b25372f4bcb896f36474f7c74e2 rdf:first N27dc8c0323914ecea8d4b7cd247338e8
172 rdf:rest N5865df9af61741c8bf22a6733ea20aa7
173 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
174 schema:name Medical and Health Sciences
175 rdf:type schema:DefinedTerm
176 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
177 schema:name Clinical Sciences
178 rdf:type schema:DefinedTerm
179 sg:journal.1036535 schema:issn 1750-1172
180 schema:name Orphanet Journal of Rare Diseases
181 rdf:type schema:Periodical
182 sg:person.01020207777.87 schema:affiliation https://www.grid.ac/institutes/grid.452372.5
183 schema:familyName Albiñana
184 schema:givenName Virginia
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01020207777.87
186 rdf:type schema:Person
187 sg:person.01047674527.54 schema:affiliation https://www.grid.ac/institutes/grid.418281.6
188 schema:familyName Recio-Poveda
189 schema:givenName Lucia
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047674527.54
191 rdf:type schema:Person
192 sg:person.01057140447.98 schema:affiliation https://www.grid.ac/institutes/grid.452372.5
193 schema:familyName Botella
194 schema:givenName Luisa María
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01057140447.98
196 rdf:type schema:Person
197 sg:person.01322311471.10 schema:affiliation https://www.grid.ac/institutes/grid.413514.6
198 schema:familyName Padial
199 schema:givenName Luis Rodríguez
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322311471.10
201 rdf:type schema:Person
202 sg:person.07742071351.62 schema:affiliation https://www.grid.ac/institutes/grid.426047.3
203 schema:familyName Villar Gómez de las Heras
204 schema:givenName Karina
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07742071351.62
206 rdf:type schema:Person
207 sg:pub.10.1007/s00417-014-2660-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021055943
208 https://doi.org/10.1007/s00417-014-2660-0
209 rdf:type schema:CreativeWork
210 sg:pub.10.1007/s10517-006-0249-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046930187
211 https://doi.org/10.1007/s10517-006-0249-2
212 rdf:type schema:CreativeWork
213 sg:pub.10.1007/s10549-011-1505-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051311429
214 https://doi.org/10.1007/s10549-011-1505-3
215 rdf:type schema:CreativeWork
216 sg:pub.10.1038/ejhg.2010.175 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034174369
217 https://doi.org/10.1038/ejhg.2010.175
218 rdf:type schema:CreativeWork
219 sg:pub.10.1038/eye.2012.259 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019328739
220 https://doi.org/10.1038/eye.2012.259
221 rdf:type schema:CreativeWork
222 sg:pub.10.1186/s13023-015-0343-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021469829
223 https://doi.org/10.1186/s13023-015-0343-5
224 rdf:type schema:CreativeWork
225 https://app.dimensions.ai/details/publication/pub.1077312261 schema:CreativeWork
226 https://app.dimensions.ai/details/publication/pub.1078585829 schema:CreativeWork
227 https://app.dimensions.ai/details/publication/pub.1083003894 schema:CreativeWork
228 https://doi.org/10.1016/j.ajo.2006.02.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024129914
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1016/j.ijporl.2011.01.028 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001699378
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1016/j.jcjo.2014.07.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009229111
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1016/j.jcma.2013.09.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030334455
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1016/j.oftal.2011.10.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009711802
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1016/j.ophtha.2008.04.033 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003738503
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1016/j.pdpdt.2014.02.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023357042
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1016/j.pdpdt.2015.10.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012392419
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1016/j.semcancer.2012.05.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018462490
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1016/j.vph.2010.08.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032262192
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1016/j.wneu.2015.11.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038518597
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1016/s0140-6736(03)13643-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026836976
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1016/s0929-693x(12)71167-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043411777
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1055/s-0031-1291300 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057249368
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1056/nejmc0708819 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019302191
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1093/qjmed/77.2.1151 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059986214
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1097/01.iae.0000244659.62202.ee schema:sameAs https://app.dimensions.ai/details/publication/pub.1033390356
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1101/cshperspect.a006460 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039269309
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1111/j.1365-2133.2010.09848.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1050039524
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1111/j.1600-0420.2006.00825.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1028490917
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1111/j.1755-3768.2009.01611.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1052912596
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1160/th11-11-0809 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063292920
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1177/0009922813492885 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034690595
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1200/jco.2010.33.5422 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009936880
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1542/peds.2008-3458 schema:sameAs https://app.dimensions.ai/details/publication/pub.1067827626
277 rdf:type schema:CreativeWork
278 https://doi.org/10.18632/oncotarget.197 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014843950
279 rdf:type schema:CreativeWork
280 https://doi.org/10.18632/oncotarget.343 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024984930
281 rdf:type schema:CreativeWork
282 https://doi.org/10.3171/2011.12.peds11503 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071076434
283 rdf:type schema:CreativeWork
284 https://doi.org/10.3892/mmr.2015.4170 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071523119
285 rdf:type schema:CreativeWork
286 https://doi.org/10.4103/0378-6323.51238 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022652823
287 rdf:type schema:CreativeWork
288 https://doi.org/10.5301/ejo.5000322 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072751105
289 rdf:type schema:CreativeWork
290 https://doi.org/10.5966/sctm.2015-0076 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026196688
291 rdf:type schema:CreativeWork
292 https://www.grid.ac/institutes/grid.413514.6 schema:alternateName Hospital Virgen de la Salud
293 schema:name Hospital Virgen de la Salud (SESCAM), Toledo, Spain
294 rdf:type schema:Organization
295 https://www.grid.ac/institutes/grid.418281.6 schema:alternateName Centro de Investigaciones Biológicas
296 schema:name Centro de Investigaciones Biológicas, CSIC, Madrid, Spain
297 rdf:type schema:Organization
298 https://www.grid.ac/institutes/grid.426047.3 schema:alternateName Servicio de Salud de Castilla La Mancha
299 schema:name SSCC - Servicio de Salud de Castilla-La Mancha (SESCAM), Toledo, Spain
300 rdf:type schema:Organization
301 https://www.grid.ac/institutes/grid.452372.5 schema:alternateName Centre for Biomedical Network Research on Rare Diseases
302 schema:name Centro de Investigaciones Biológicas, CSIC, Madrid, Spain
303 Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain
304 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...